Cargando…
The Use of Omnipod® 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes With Suboptimal Glycemic Management: From Injections to Closed-Loop Therapy
Advances in automated insulin delivery (AID), integrating continuous glucose monitoring (CGM), insulin pump therapy, and dynamic insulin modulation, have mostly centered on type 1 diabetes. Very little data exists to characterize the use of AID in adults with type 2 diabetes in the outpatient settin...
Autores principales: | Bode, Bruce W, Peters, Anne, Carlson, Anders L, Dumais, Bonnie, Lowen, Steven, Vienneau, Todd, Huyett, Lauren, Ly, Trang T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090121/ http://dx.doi.org/10.1210/jendso/bvab048.980 |
Ejemplares similares
-
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
por: Davis, Georgia M., et al.
Publicado: (2023) -
Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)
por: Buckingham, Bruce A, et al.
Publicado: (2021) -
OR22-3 Closed-Loop Glucagon Pump: A Novel and Effective Strategy for Post-Bariatric Hypoglycemia
por: Mulla, Christopher, et al.
Publicado: (2019) -
SUN-151 Improved Glycemic Control with Automated Insulin Pump (AIP) Technology
por: Amole, Morolake, et al.
Publicado: (2019) -
OR14-5 Challenges in implementing Hybrid Closed Loop Insulin Pump Therapy (medtronic 670g) In A 'Real World' Clinical Setting.
por: Goodwin, Gregory, et al.
Publicado: (2019)